Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?
The company has shown its revolutionary technology can deliver life-changing therapies. Now, it's about whether CRISPR Therapeutics can replicate the success across its promising pipeline.
Our genetics are like nature's roadmap. Our DNA dictates what color eyes we have, how tall we become, and our physical abilities.
Our genetics also influence our susceptibility to certain conditions or diseases. Some biotechnology companies, such as CRISPR Therapeutics (NASDAQ: CRSP), hope to use gene editing technology to treat, or even cure, diseases that existing drugs cannot.
It's been a long journey for CRISPR Therapeutics, which went public in 2016 and has declined over 80% from its 2021 peak. But now, the business could finally be nearing liftoff. Can buying today and holding it forever make you a millionaire?
